The communication software developer boosted its total funding to $91m in a round that included Anschutz Investment Company.

The immunotherapy developer, which is majority owned by BGI Group, has secured $17.8m in a GF Securities-led round that will fund clinical work on its lead product candidate.

The data centre technology developer will put the proceeds from the CUI-led round into its marketing and research and development activities.

BioLeaders is investing $10m in an as yet unnamed spinout from Weizmann Institute of Science working on a genetic drug for cancer.

A round up of all the news on www.globalcorporateventuring.com for our subscribers.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Alibaba, Chongqing Changan Automobile, Dongfeng Motor, FAW, Suning and Tencent have joined forces to form a $1.46bn vehicle that will invest in the on-demand ride space.

CapitalG-backed UiPath is in the process of raising $400m in a round that will be led by an unnamed public institutional investor at a $7bn valuation.

Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.

The payment card services provider, which counts Visa, Commerzbank and CreditEase as investors, will seek a valuation of almost $1.9bn in the round.